Orthologs of the genes encoding the ligands ( GCG, GIP ), their receptors ( GLP-1R, GIPR ) and DPP-4 have been identified in a range of vertebrate species (reviewed in refs 8, 9, 10)
Novo Nordisk's Phase 3 REDEFINE 1 interim readout (2024) reported approximately 22.7% mean weight reduction at 68 weeks for Cagrisema 2.4 mg/2.4 mg versus 8.1% for semaglutide 2.4 mg alone [7][8]
Knowing whether you carry genetic variants that affect appetite signaling or peptide sensitivity can motivate consistencybecause you'll understand that your treatment is tailored to your unique biology, not a one-size-fits-all approach
Temperature-related benefits (important for sperm health) accumulate over 2-3 months
Jalleh RJ, Jones K, Nauck M, Horowitz M